This oral glutathione study illustrates why a multi-site result should not become a blanket claim about the entire body. The location of each measurement matters. Primary trial
What the trial reported
Sixty healthy medical students completed a four-week randomized, double-blind comparison of oral glutathione capsules with placebo. Melanin indices were measured at six sites. Indices decreased at all six in the active group, but the between-group differences were statistically significant at two: one facial site and one sun-exposed forearm site. The authors explicitly stated that long-term safety was not established. Primary trial
Our appraisal: distinguish direction from comparison
Six measurements moving in the same direction within a group is not the same as six demonstrated advantages over placebo. The comparison, uncertainty, and number of tests should remain attached to each result.
An invented example helps: if an active group decreases by three units at a site and placebo decreases by two, the comparative estimate is not the active group's three-unit change. Its uncertainty also depends on the study's data and analysis, not simply the subtraction. A useful summary avoids presenting within-group change as treatment-specific benefit.
Scope and relevance
An instrument's melanin index is not automatically a measure of improved health, wellbeing, or satisfaction. Skin tone is not a hierarchy of health or worth. This page evaluates a measurement claim rather than promoting lighter skin as desirable.
The formulation and route are also essential. Oral capsule findings do not establish effects or safety for injectable preparations, topical mixtures, or a differently characterized material. Our full-paper review should inspect site selection, prespecification, baseline adjustment, multiple comparisons, individual variability, and the complete adverse-event account.
Frequently asked questions
Did all six sites show a significant placebo difference?
No. The reported significant differences occurred at two sites.
Was the intervention injectable glutathione?
No. It was an oral capsule intervention.
Does an index change equal a health benefit?
Not automatically. The claimed outcome must match the measured construct.
Did the trial establish long-term safety?
No. The authors specifically identified that evidence gap.
Can the result be generalized to all ages and skin types?
The selected sample does not support unrestricted generalization.
Are within-group and between-group changes interchangeable?
No. They answer different questions.
What was inspected for this record?
The primary indexed abstract and record. This is not a complete review of glutathione or a cosmetic treatment recommendation.